Subscribe
shutterstock_1075910645_grand_warszawski
Grand Warszawski / Shutterstock.com
19 October 2020AmericasSarah Morgan

Kilpatrick Townsend hires litigation team from DLA Piper

Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Fed Circuit refuses Amgen unit appeal in win for Sanofi
15 October 2020   The US Court of Appeals for the Federal Circuit has dismissed Immunex’s appeal against a decision invalidating its patent on treating inflammatory disorders.
Biotechnology
Regeneron sued over antibody protein used to treat Trump’s COVID-19 symptoms
6 October 2020   Regeneron Pharmaceuticals is facing claims that its “antibody cocktail”, which was administered to President Donald Trump to treat his COVID-19 symptoms, was developed with the unauthorised use of a fluorescent protein.
Americas
Cozen O'Connor snaps up Kilpatrick Townsend duo
28 October 2020   Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Big Pharma
Fed Circuit refuses Amgen unit appeal in win for Sanofi
15 October 2020   The US Court of Appeals for the Federal Circuit has dismissed Immunex’s appeal against a decision invalidating its patent on treating inflammatory disorders.
Biotechnology
Regeneron sued over antibody protein used to treat Trump’s COVID-19 symptoms
6 October 2020   Regeneron Pharmaceuticals is facing claims that its “antibody cocktail”, which was administered to President Donald Trump to treat his COVID-19 symptoms, was developed with the unauthorised use of a fluorescent protein.
Americas
Cozen O'Connor snaps up Kilpatrick Townsend duo
28 October 2020   Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.

More on this story

Big Pharma
Fed Circuit refuses Amgen unit appeal in win for Sanofi
15 October 2020   The US Court of Appeals for the Federal Circuit has dismissed Immunex’s appeal against a decision invalidating its patent on treating inflammatory disorders.
Biotechnology
Regeneron sued over antibody protein used to treat Trump’s COVID-19 symptoms
6 October 2020   Regeneron Pharmaceuticals is facing claims that its “antibody cocktail”, which was administered to President Donald Trump to treat his COVID-19 symptoms, was developed with the unauthorised use of a fluorescent protein.
Americas
Cozen O'Connor snaps up Kilpatrick Townsend duo
28 October 2020   Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent